Global Markets Direct Market Research Reports

TITLE Actions
Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Adrenoleukodystrophy (Adrenomyeloneuropathy/ Schilder-Addison Complex) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Adrenoleukodystrophy - Drugs In ...

Spinocerebellar Ataxia (SCA) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Spinocerebellar Ataxia (SCA) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Spinocerebellar Ataxia - Drugs In Development, 2021, provides an overview ...

Nephrotic Syndrome (Genitourinary Disorders) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Nephrotic Syndrome (Genitourinary Disorders) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nephrotic Syndrome - Drugs In Development, 2021, provides ...

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) (Genitourinary Disorders) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) (Genitourinary Disorders) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide End-Stage Kidney D...

Aplastic Anemia (Hematology) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Aplastic Anemia (Hematology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Aplastic Anemia - Drugs In Development, 2021, provides an overview of the ...

Fanconi Anemia (Hematology) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Fanconi Anemia (Hematology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Fanconi Anemia - Drugs In Development, 2021, provides an overview of the Fa...

Hypereosinophilic Syndrome (Hematology) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Hypereosinophilic Syndrome (Hematology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypereosinophilic Syndrome - Drugs In Development, 2021, provid...

Hypoparathyroidism (Hormonal Disorders) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Hypoparathyroidism (Hormonal Disorders) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypoparathyroidism - Drugs In Development, 2021, provides an ov...

Hypothyroidism (Hormonal Disorders) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Hypothyroidism (Hormonal Disorders) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Hypothyroidism - Drugs In Development, 2021, provides an overview o...

Systemic Lupus Erythematosus (Immunology) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2500 Onwards | By Global Markets Direct

Systemic Lupus Erythematosus (Immunology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Systemic Lupus Erythematosus - Drugs In Development, 2021, pr...

Pemphigus Vulgaris (Immunology) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Pemphigus Vulgaris (Immunology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Pemphigus Vulgaris - Drugs In Development, 2021, provides an overview o...

Anaphylaxis (Immunology) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Anaphylaxis (Immunology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Anaphylaxis - Drugs In Development, 2021, provides an overview of the Anaphyla...

Lung Transplant Rejection (Immunology) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Lung Transplant Rejection (Immunology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Lung Transplant Rejection - Drugs In Development, 2021, provides...

Burkholderia pseudomallei Infections (Melioidosis) (Infectious Disease) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Burkholderia pseudomallei Infections (Melioidosis) (Infectious Disease) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Burkholderia pseudomallei Infec...

Escherichia coli Infections (Infectious Disease) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Escherichia coli Infections (Infectious Disease) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Escherichia coli Infections - Drugs In Development, 20...

Tularaemia (Infectious Disease) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Tularaemia (Infectious Disease) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Tularaemia - Drugs In Development, 2021, provides an overview of the Tu...

Diphtheria (Infectious Disease) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Diphtheria (Infectious Disease) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Diphtheria - Drugs In Development, 2021, provides an overview of the Di...

Vancomycin-Resistant Enterococcus faecium Infections (Infectious Disease) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Vancomycin-Resistant Enterococcus faecium Infections (Infectious Disease) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Vancomycin-Resistant Enteroco...

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections (Infectious Disease) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2500 Onwards | By Global Markets Direct

Methicillin-Resistant Staphylococcus aureus (MRSA) Infections (Infectious Disease) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Methicillin-Resistan...

Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections (Infectious Disease) - Drugs in Development, 2021
Published in Sep 2021 | US $ 2000 Onwards | By Global Markets Direct

Methicillin-Susceptible Staphylococcus aureus (MSSA) Infections (Infectious Disease) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Methicillin-Suscep...

We are on:

Need Help?

Buy Any Report Avail 20% Discount. Coupon Code: DEC20

Connect for special KNOWLEDGE STORE Deals
Subscription starts at $ 20K